![Alan Bash](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alan Bash
Chief Executive Officer at
LEGEND BIOTECH CORPORATION
Net worth: 158 992 $ as of 31/07/2026
Profile
Alan S.
Bash is Chief Executive Officer at Legend Biotech Corp.
starting in 2026.
Former roles include President, Chief Executive Officer & Director at Checkmate Pharmaceuticals, Inc. in 2022; Chief Executive Officer & Director at ZielBio, Inc. from 2022 to 2024; and Senior Vice President-Commercial Model Innovation at Bristol Myers Squibb Co. Education includes undergraduate studies at Georgetown University and an MBA from Columbia Business School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
LEGEND BIOTECH CORP. 0.01% | 24/07/2026 | 17,142 ( 0.01% ) | 158 992 $ | 31/07/2026 |
Alan Bash active positions
| Companies | Position | Start |
|---|---|---|
| LEGEND BIOTECH CORPORATION | Chief Executive Officer | 24/07/2026 |
Former positions of Alan Bash
| Companies | Position | End |
|---|---|---|
ZielBio, Inc.
 ZielBio, Inc. Medical SpecialtiesHealth Technology Develops a technology for identification of cancerous diseases | Chief Executive Officer | 01/10/2024 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
| CHECKMATE PHARMACEUTICALS, INC. | Chief Executive Officer | - |
Training of Alan Bash
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
26
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
ZielBio, Inc.
ZielBio, Inc. Medical SpecialtiesHealth Technology Develops a technology for identification of cancerous diseases | Health Technology |
Georgetown University
 Georgetown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Columbia Business School
 Columbia Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Checkmate Pharmaceuticals, Inc.
 Checkmate Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develop anti-cancer therapeutics | Health Technology |
Legend Biotech Corp.
 Legend Biotech Corp. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which engages in the discovery and development of novel cell therapies for oncology | Health Technology |
- Stock Market
- Insiders
- Alan Bash
